Jun-Kang Shen
Overview
Explore the profile of Jun-Kang Shen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
86
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Song H, Li Z, Huang Q, Wu C, Li M, Shen J
Ann Med
. 2024 Dec;
57(1):2443568.
PMID: 39704340
Objectives: Intervertebral disc degeneration (IVDD) is a prevalent degenerative condition associated with a high incidence rate of low back pain and disability. This study aimed to identify potential biomarkers and...
2.
Lu J, Rui J, Xu X, Shen J
Biomedicines
. 2024 Jul;
12(7).
PMID: 39062086
Background: The involvement of neutrophil-related genes (NRGs) in patients with osteosarcoma (OS) has not been adequately explored. In this study, we aimed to examine the association between NRGs and the...
3.
Zhang Y, Mao H, Wei C, Chen T, Zhao W, Chen L, et al.
Acad Radiol
. 2024 Jul;
31(12):5054-5065.
PMID: 39043515
Rationale And Objectives: Perineural invasion (PNI) is an important prognostic biomarker for prostate cancer (PCa). This study aimed to develop and validate a predictive model integrating biparametric MRI-based deep learning...
4.
Wei C, Zeng Y, Zhang R, Zhu Y, Tu J, Pan P, et al.
Quant Imaging Med Surg
. 2023 Aug;
13(8):5058-5071.
PMID: 37581045
Background: To investigate the role of native T mapping in the non-invasive quantitative assessment of renal function and renal fibrosis (RF) in chronic kidney disease (CKD) patients. Methods: A prospective...
5.
Song Y, Zhang Y, Yu Q, Chen T, Wei C, Zhang R, et al.
Front Oncol
. 2023 Feb;
13:1123141.
PMID: 36824129
Purpose: Noninvasively assessing the tumor biology and microenvironment before treatment is greatly important, and glypican-3 (GPC-3) is a new-generation immunotherapy target for hepatocellular carcinoma (HCC). This study investigated the application...
6.
Wei C, Zhang R, Wei L, Pan P, Zu H, Liu Y, et al.
Front Bioeng Biotechnol
. 2023 Jan;
10:1078342.
PMID: 36588949
Erythropoietin producing hepatocyte receptor A2 () is widely presented in the tumor cells, closely related to tumor cell migration, not cell apoptosis and proliferation. Based on its high expression in...
7.
Wang Z, Wei C, Zhang Y, Pan P, Dai G, Tu J, et al.
Biomed Res Int
. 2021 Oct;
2021:3995789.
PMID: 34671673
Objective: To evaluate the role of prostate-specific antigen density (PSAD) in different Prostate Imaging Reporting and Data System version 2.1 (PI-RADS v2.1) categories to avoid an unnecessary biopsy in transition...
8.
Wei C, Zhang Y, Pan P, Chen T, Yu H, Dai G, et al.
AJR Am J Roentgenol
. 2020 Aug;
216(5):1247-1256.
PMID: 32755220
PI-RADS version 2.1 (v2.1) introduced a number of key changes to the assessment of transition zone (TZ) lesions. The purpose of this study was to evaluate interobserver agreement and diagnostic...
9.
Wei C, Chen T, Zhang Y, Pan P, Dai G, Yu H, et al.
Eur J Radiol
. 2020 Jun;
129:109129.
PMID: 32580910
No abstract available.
10.
Wei C, Chen T, Zhang Y, Pan P, Dai G, Yu H, et al.
Eur J Radiol
. 2020 Apr;
127:108977.
PMID: 32330776
Purpose: To predict clinically significant prostate cancer (cs-PCa) by combining the Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) score based on biparametric magnetic resonance imaging (bp-MRI) and...